# Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies

> **NCT00845819** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 138 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** rhEGF + povidone iodine, chlorhexidine, & nystatin
- **DRUG:** Placebo + povidone iodine, chlorhexidine, & nystatin

## Key facts

- **NCT ID:** NCT00845819
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2015-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845819, "Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00845819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*